Evidence map›Paper›PMID 37585091›Full record

ArticleACS applied materials & interfaces2023

Spike Protein Fragments Promote Alzheimer's Amyloidogenesis.

Sujian Cao, Zhiyuan Song, Jinyu Rong, Nicholas Andrikopoulos, Xiufang Liang, Yue Wang, Guotao Peng, Feng Ding, Pu Chun Ke

Open access · greenAbstract read
In one paragraph

Article in ACS applied materials & interfaces, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Food science & nutrition · 2026
    Review
  2. Article
  3. Article
  4. Modulation of AβJournal of chemical information and modeling · 2025
    Article
  5. Article
  6. Formation of a β-Endorphin Corona Mitigates Alzheimer's Amyloidogenesis.Small (Weinheim an der Bergstrasse, Germany) · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Sujian CaoNanomedicine Center, The Great Bay Area National Institute for Nanotechnology Innovation, 136 Kaiyuan Avenue, Guangzhou, 510700, China.
Zhiyuan SongDepartment of Physics and Astronomy, Clemson University, Clemson, South Carolina 29634, United States.ORCID 0000-0003-3556-8205
Jinyu RongCollege of Environmental Science and Engineering, Tongji University, 1239 Siping Road, Shanghai 200092, China.
Nicholas AndrikopoulosNanomedicine Center, The Great Bay Area National Institute for Nanotechnology Innovation, 136 Kaiyuan Avenue, Guangzhou, 510700, China.ORCID 0000-0001-8936-3534
Xiufang LiangNanomedicine Center, The Great Bay Area National Institute for Nanotechnology Innovation, 136 Kaiyuan Avenue, Guangzhou, 510700, China.
Yue WangNanomedicine Center, The Great Bay Area National Institute for Nanotechnology Innovation, 136 Kaiyuan Avenue, Guangzhou, 510700, China.
Guotao PengCollege of Environmental Science and Engineering, Tongji University, 1239 Siping Road, Shanghai 200092, China.ORCID 0000-0001-7169-9961
Feng DingDepartment of Physics and Astronomy, Clemson University, Clemson, South Carolina 29634, United States.ORCID 0000-0003-1850-6336
Pu Chun KeNanomedicine Center, The Great Bay Area National Institute for Nanotechnology Innovation, 136 Kaiyuan Avenue, Guangzhou, 510700, China.ORCID 0000-0003-2134-0859
National Engineering Research Center for Nanotechnology · CNClemson University · USTongji University · CN

Funding

Tissue Structural and Neural Remodeling in Human Sacroiliac JointP20GM121342 · NIGMS · CLEMSON UNIVERSITY · PI Hai Yao · 2018 to 2026
$24.7M
Inhibition of Human Islet Amyloid Polypeptide AggregationR35GM145409 · NIGMS · CLEMSON UNIVERSITY · PI Feng Ding · 2022 to 2026
$2.0M
NIGMS NIH HHS P20 GM121342NIGMS NIH HHS R35 GM145409
6 · The paper itself

Abstract

Alzheimer's disease (AD) is a major cause of dementia inducing memory loss, cognitive decline, and mortality among the aging population. While the amyloid aggregation of peptide Aβ has long been implicated in neurodegeneration in AD, primarily through the production of toxic polymorphic aggregates and reactive oxygen species, viral infection has a less explicit role in the etiology of the brain disease. On the other hand, while the COVID-19 pandemic is known to harm human organs and function, its adverse effects on AD pathobiology and other human conditions remain unclear. Here we first identified the amyloidogenic potential of

Indexed as

Alzheimer DiseaseCOVID-19Virus DiseasesAgedAmyloid beta-PeptidesAnimalsHumansPandemicsPeptide FragmentsPost-Acute COVID-19 SyndromeSARS-CoV-2Spike Glycoprotein, CoronavirusZebrafishAmyloid beta-PeptidesPeptide FragmentsSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Alzheimer’s diseaseamyloid βSARS-CoV-2spike proteinvirus

Identifiers

PMID37585091
PMCPMC10480042
OpenAlexW4385851328

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.